A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

Clinical trial NCT06765668 · RECRUITING

Trial details

NCT number: NCT06765668
Sponsor: Impax Laboratories, LLC
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2025-02-12
Primary completion: 2025-11-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.